These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, Graziano S, Brinker JA. N Engl J Med; 1992 Feb 13; 326(7):425-30. PubMed ID: 1732769 [Abstract] [Full Text] [Related]
4. The safety and cost-effectiveness of low osmolar contrast media. Can economic analysis determine the real worth of a new technology? Henry DA, Evans DB, Robertson J. Med J Aust; 1991 Jun 03; 154(11):766-72. PubMed ID: 1828529 [Abstract] [Full Text] [Related]
5. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. N Engl J Med; 1992 Feb 13; 326(7):431-6. PubMed ID: 1732770 [Abstract] [Full Text] [Related]
6. Selective use of low-osmolality contrast agents for i.v. urography and CT: safety and effect on cost. Hunter TB, Dye J, Duval JF. AJR Am J Roentgenol; 1994 Oct 13; 163(4):965-8. PubMed ID: 8092044 [Abstract] [Full Text] [Related]
7. The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media. Caro JJ, Trindade E, McGregor M. AJR Am J Roentgenol; 1992 Oct 13; 159(4):869-74. PubMed ID: 1529856 [Abstract] [Full Text] [Related]
8. Cost-effectiveness of unenhanced MR imaging vs contrast-enhanced CT of the abdomen or pelvis. Lessler DS, Sullivan SD, Stergachis A. AJR Am J Roentgenol; 1994 Jul 13; 163(1):5-9. PubMed ID: 8010246 [Abstract] [Full Text] [Related]
10. [Selection of contrast media: current status of understanding]. Briguori C. G Ital Cardiol (Rome); 2009 Feb 13; 10(2):79-87. PubMed ID: 19348144 [Abstract] [Full Text] [Related]
11. Selective use of low osmolality contrast agents: cost and benefits. Ohnesorgen EG, Yoshino MT. Radiol Technol; 1988 Feb 13; 59(6):499-502. PubMed ID: 3136507 [Abstract] [Full Text] [Related]
17. Intravenous contrast media: use and associated mortality. Cashman JD, McCredie J, Henry DA. Med J Aust; 1991 Nov 04; 155(9):618-23. PubMed ID: 1943961 [Abstract] [Full Text] [Related]
18. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer. Rankins NC, Secord AA, Jewell E, Havrilesky LJ, Soper JT, Myers E. Gynecol Oncol; 2007 Aug 04; 106(2):388-93. PubMed ID: 17509672 [Abstract] [Full Text] [Related]
20. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis. Caro JJ, Trindade E, McGregor M. AJR Am J Roentgenol; 1991 Apr 04; 156(4):825-32. PubMed ID: 1825900 [Abstract] [Full Text] [Related] Page: [Next] [New Search]